Immunotherapy for fungal infections with special emphasis on central nervous system infections

Iyer G Parameswaran1, Brahm H Segal

  • 1Division of Infectious Diseases, University at Buffalo School of Medicine, Buffalo, NY, USA.

Neurology India
|October 9, 2007
PubMed

Insights

Opportunistic fungal infections pose significant risks to immunocompromised individuals. Immunotherapy strategies, including vaccines, show promise for treating fungal diseases like cryptococcosis and coccidioidomycosis, especially those affecting the central nervous system (CNS).

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Opportunistic fungal infections are a leading cause of illness and death in immunocompromised patients.
  • Fungi possess sophisticated survival mechanisms against host defenses and environmental challenges like nutrient scarcity and immune evasion.

Purpose of the Study:

  • To review immunopathogenesis of fungal infections.
  • To explore immunotherapy strategies for fungal diseases, particularly cryptococcosis and coccidioidomycosis affecting the central nervous system (CNS).

Main Methods:

  • Literature review focusing on fungal immunopathogenesis and immunotherapy.
  • Analysis of fungal adaptation to host stressors and immune evasion tactics.
  • Examination of immunotherapy approaches including enhancing phagocyte function and stimulating adaptive immunity.

Main Results:

  • Fungal infections present complex challenges due to fungal adaptation and host immune evasion.
  • Immunotherapy strategies aim to boost host defenses, including phagocyte activation and antigen-specific immunity.
  • Cryptococcosis and coccidioidomycosis, with their propensity for CNS involvement, are key areas for therapeutic development.

Conclusions:

  • Understanding fungal immunopathogenesis is crucial for developing effective immunotherapies.
  • Therapeutic strategies must be personalized to specific immunocompromised states.
  • Immune-based therapies for fungal CNS infections are in early stages and require further clinical investigation.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...